We previously found that the mRNA and protein levels of HABP1 significantly increased in breast cancer tissues, and upregulation of HABP1 was significantly associated with poor prognosis of breast cancer, including triple-negative breast cancer [12, 16]. This evidence concerns the gene C1QBP and triple-negative breast carcinoma.